Biovie (BIVI) Payables (2013 - 2026)
Biovie (BIVI) recorded Payables of $3.7 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 68.4% from $2.2 million a year earlier and up 129.9% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Payables (2013 - 2026) Analysis & Trends
Starting with fiscal Q4 2013, Biovie's Payables history includes 49 quarters.
- Annual Payables has a five-year compound annual growth rate of 30.0% (FY2021 to FY2026).
- Across earlier fiscal years, Payables came in at $2.2 million in FY2025 (-76.3%), $9.29 million in FY2024 (-26.2%), $12.58 million in FY2023 (+415.0%) and $2.44 million in FY2022 (+145.2%).
- The fiscal Q4 2026 figure is the highest quarterly Payables since fiscal Q1 2025.
- On a year-over-year basis, Payables rose in two of the last eight quarters, with an average decline of 27.8%.
- Peak year-over-year performance for Payables in the last five years was growth of 831.0% in fiscal Q3 2023, against a decline of 90.0% in fiscal Q2 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.61 million (Q3 2026), $2.92 million (Q2 2026) and $1.57 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Biovie | 11.62 Mn | 11.62 Mn | - | 3.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 6.77 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 13.80 Mn |
| Sep 30, 2023 | 12.05 Mn |
| Jun 30, 2023 | 12.58 Mn |
| Mar 31, 2023 | 11.23 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 679,393.00 |
API Access
Biovie Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();